161 related articles for article (PubMed ID: 24092425)
1. Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.
Jaeger M; Nör C; de Farias CB; Abujamra AL; Schwartsmann G; Brunetto AL; Roesler R
Childs Nerv Syst; 2013 Dec; 29(12):2145-50. PubMed ID: 24092425
[TBL] [Abstract][Full Text] [Related]
2. Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
Jaeger M; Ghisleni EC; Fratini L; Brunetto AL; Gregianin LJ; Brunetto AT; Schwartsmann G; de Farias CB; Roesler R
Childs Nerv Syst; 2016 Jan; 32(1):61-4. PubMed ID: 26590027
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.
Meco D; Servidei T; Riccardi A; Ferlini C; Cusano G; Zannoni GF; Giangaspero F; Riccardi R
Neuro Oncol; 2009 Jun; 11(3):250-9. PubMed ID: 19033425
[TBL] [Abstract][Full Text] [Related]
4. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.
Götschel F; Berg D; Gruber W; Bender C; Eberl M; Friedel M; Sonntag J; Rüngeler E; Hache H; Wierling C; Nietfeld W; Lehrach H; Frischauf A; Schwartz-Albiez R; Aberger F; Korf U
PLoS One; 2013; 8(6):e65403. PubMed ID: 23762360
[TBL] [Abstract][Full Text] [Related]
5. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
Chang Q; Chen Z; You J; McNutt MA; Zhang T; Han Z; Zhang X; Gong E; Gu J
J Neurooncol; 2007 Sep; 84(3):263-7. PubMed ID: 17453147
[TBL] [Abstract][Full Text] [Related]
6. BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.
Schmidt AL; de Farias CB; Abujamra AL; Kapczinski F; Schwartsmann G; Brunetto AL; Roesler R
J Mol Neurosci; 2010 Mar; 40(3):303-10. PubMed ID: 19642024
[TBL] [Abstract][Full Text] [Related]
7. The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
Thompson EM; Whitney NL; Wu YJ; Neuwelt EA
J Neurosurg Pediatr; 2013 Jan; 11(1):60-7. PubMed ID: 23082872
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of murine models of medulloblastoma extraneural growth in bone.
Grunda JM; Wang D; Clines GA
Clin Exp Metastasis; 2013 Aug; 30(6):769-79. PubMed ID: 23494821
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
Yuan J; Llamas Luceño N; Sander B; Golas MM
Cell Oncol (Dordr); 2017 Jun; 40(3):263-279. PubMed ID: 28429280
[TBL] [Abstract][Full Text] [Related]
10. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
Aguilera DG; Das CM; Sinnappah-Kang ND; Joyce C; Taylor PH; Wen S; Hasselblatt M; Paulus W; Fuller G; Wolff JE; Gopalakrishnan V
J Neurooncol; 2009 Jul; 93(3):303-18. PubMed ID: 19148581
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR.
Laschuk Herlinger A; Lovatto Michaelsen G; Sinigaglia M; Fratini L; Nogueira Debom G; Braganhol E; Brunetto de Farias C; Lunardi Brunetto A; Tesainer Brunetto A; da Cunha Jaeger M; Roesler R
Neuromolecular Med; 2023 Dec; 25(4):573-585. PubMed ID: 37740824
[TBL] [Abstract][Full Text] [Related]
13. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.
Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
BMC Med; 2012 Mar; 10():28. PubMed ID: 22436374
[TBL] [Abstract][Full Text] [Related]
14. The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Rossi A; Russo G; Puca A; La Montagna R; Caputo M; Mattioli E; Lopez M; Giordano A; Pentimalli F
Int J Cancer; 2009 Jul; 125(1):235-43. PubMed ID: 19358275
[TBL] [Abstract][Full Text] [Related]
15. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
Abouantoun TJ; MacDonald TJ
Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143
[TBL] [Abstract][Full Text] [Related]
16. Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines.
Cavazzoni A; Alfieri RR; Cretella D; Saccani F; Ampollini L; Galetti M; Quaini F; Graiani G; Madeddu D; Mozzoni P; Galvani E; La Monica S; Bonelli M; Fumarola C; Mutti A; Carbognani P; Tiseo M; Barocelli E; Petronini PG; Ardizzoni A
Mol Cancer; 2012 Dec; 11():91. PubMed ID: 23234355
[TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway.
Gumireddy K; Sutton LN; Phillips PC; Reddy CD
Clin Cancer Res; 2003 Sep; 9(11):4052-9. PubMed ID: 14519626
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy.
Bedi A; Chang X; Noonan K; Pham V; Bedi R; Fertig EJ; Considine M; Califano JA; Borrello I; Chung CH; Sidransky D; Ravi R
Mol Cancer Ther; 2012 Nov; 11(11):2429-39. PubMed ID: 22927667
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma.
Kurai J; Chikumi H; Hashimoto K; Takata M; Sako T; Yamaguchi K; Kinoshita N; Watanabe M; Touge H; Makino H; Igishi T; Hamada H; Yano S; Shimizu E
Int J Oncol; 2012 Nov; 41(5):1610-8. PubMed ID: 22922885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
